Effect and safety of TACE combined with lenvatinib mesylate and combined with apatinib in the treatment of intermediate and advanced primary liver cancer

YAO Min, YANG Jun-jun, GUO Xiao-hong, XU Ai-bing

Chinese Hepatolgy . 2025, (12): 1647 -1651 .